Endovascular therapy for acute ischemic stroke: A systematic review and meta-analysis

Mayo Clinic Proceedings

Volumn 88, Issue 10, 2013, Pages 1056-1065

  Singh, Balwinder ^a   Parsaik, Ajay K ^a   Prokop, Larry J ^a   Mittal, Manoj K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HEPARIN;

ARTICLE; BRAIN ISCHEMIA; COCHRANE LIBRARY; DISEASE SEVERITY; DOSE RESPONSE; EMBASE; ENDOVASCULAR THERAPY; FIBRINOLYTIC THERAPY; HIGH RISK PATIENT; HUMAN; INFORMATION RETRIEVAL; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SAMPLE SIZE; STANDARD; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; THERAPY;

EID: 84888609442     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.07.015     Document Type: Article

References (28)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statisticse2012 update: a report from the American Heart Association. Circulation. 2012; 125(1):188-197.
2. The National Institute of Neurological Disorders and Stroke rt- PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581-1587.
3. Rha J-H, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38(3):967-973.
4. Chimowitz MI. Endovascular treatment for acute ischemic strokeestill unproven. N Engl J Med. 2013;368(10):952-955.
5. Nam J, Jing H, O'Reilly D. Intra-arterial thrombolysis vs. standard treatment or intravenous thrombolysis in adults with acute ischemic stroke: a systematic review and meta-analysis [published online ahead of print January 7, 2013]. Int J Stroke. doi: 10.1111/j.1747-4949. 2012.00914.x. Accessed August 28, 2013.
6. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368(10):893-903.
7. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368(10): 904-913.
8. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368(10):914-923.
9. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
10. University of York, Center for Reviews and Dissemination. PROSPERO: International prospective register of systematic reviews. http://www.crd.york. ac.uk/PROSPERO/display-record.asp?ID=CRD42013003838. Accessed August 2013.
11. Cohen JA. Coefficient of agreement for nominal scales educational and psychological measurement. Educ Psychol Meas. 1960;20(1):37-46.
12. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-607.
13. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
14. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2001;135(11):982-989.
15. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011]. The Cochrane Collaboration; 2011. http://www.cochranehandbook.org. Accessed August 28, 2013.
16. Mazighi M, Serfaty JM, Labreuche J, et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol. 2009;8(9):802-809.
17. Sun CH, Nogueira RG, Glenn BA, et al. "Picture to puncture": a novel time metric to enhance outcomes in patients transferred for endovascular reperfusion in acute ischemic stroke. Circulation. 2013;127(10):1139-1148.
18. Gross RA, Johnston KC. Levels of evidence: taking neurology to the next level. Neurology. 2009;72(1):8-10.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
21. Ciccone A, Valvassori L, Ponzio M, et al. Intra-arterial or intravenous thrombolysis for acute ischemic stroke? the SYNTHESIS pilot trial. J Neurointerv Surg. 2010;2(1):74-79.
22. Sen S, Huang DY, Akhavan O, Wilson S, Verro P, Solander S. IV vs. IA TPA in acute ischemic stroke with CT angiographic evidence of major vessel occlusion: a feasibility study. Neurocrit Care. 2009;11(1):76-81.
23. Nordic Cochrane Centre, Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: Nordic Cochrane Centre, Cochrane Collaboration; 2011.
24. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53(11): 1119-1129.
25. Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380(9849):1231-1240.
26. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380(9849):1241- 1249.
27. Sheth KN, Terry JB, Nogueira RG, et al. Advanced modality imaging evaluation in acute ischemic stroke may lead to delayed endovascular reperfusion therapy without improvement in clinical outcomes. J Neurointerv Surg. 2013;5(suppl 1):i62-i65.
28. Broussalis E, Trinka E, Hitzl W, Wallner A, Chroust V, Killer- Oberpfalzer M. Comparison of stent-retriever devices versus the Merci retriever for endovascular treatment of acute stroke. Am J Neuroradiol. 2013;34(2):366-372.